**Core tip:** Patients with coarctation of the aorta are at risk for a variety of short- and long-term complications after surgical repair. Endothelin-1 (ET-1) is a peptide hormone known to cause both cardiac myocyte hypertrophy and vasoconstriction that has been linked to late ventricular hypertrophy in this population. Peri-operative endothelin concentration in this population has not been previously defined. We demonstrate that neonates with coarctation of the aorta have high pre-operative ET-1 levels that decrease post-operatively. Older coarctation patients have more modest ET-1 activation that is unchanged post-operatively. These findings suggest two distinct patterns of ET-1 activation within this population.

INTRODUCTION
============

Isolated coarctation of the aorta (CoA) is found in 800 of every million live births, approximately 8% of all congenital heart disease\[[@B1]\]. Open surgical repair *via* thoracotomy or sternotomy is required for most patients presenting with severe obstruction. Although perioperative mortality is low in the modern era, the post-operative course is frequently complicated by either low cardiac output syndrome or recalcitrant hypertension\[[@B2],[@B3]\]. Additionally, these children are at significant risk for long-term complications including persistent hypertension, a hypertensive response to exercise, altered cardiac mechanics, and left ventricular (LV) hypertrophy\[[@B4],[@B5]\].

Vascular and cardiac changes are, in many cases, already present at the time of initial surgery. Pre-operatively, approximately 65% of all children with CoA will have LV hypertrophy and 33% of the subset who are diagnosed as neonates will have evidence of pulmonary hypertension\[[@B6]\]. Such echocardiographic evidence of physiologic derangements, present at diagnosis, suggests that there may be early activation of critical pathologic pathways. Better understanding of such pathways and their patterns of activation offers significant promise to understand the mechanisms of disease progression, improve prognostic accuracy, and guide future therapy.

Endothelin-1 (ET-1) is a 21-amino acid vasoactive peptide hormone with endocrine and paracrine effects. Previous mechanistic *in vitro* studies have demonstrated the capacity for ET-1 to cause vasoconstriction in both the pulmonary and systemic vasculature\[[@B7]\] as well as cardiac myocyte hypertrophy\[[@B8],[@B9]\]. Additionally, a recent study showed increased ET-1 blood concentration was associated with left ventricular hypertrophy in a mouse model of coarctation of the aorta\[[@B10]\]. Clinical data in human subjects, however, are quite limited. While ET-1 concentration is increased compared to controls at late follow-up after coarctation repair\[[@B11]\], the clinical implications of this finding are yet to be evaluated. Further, no prior study has assessed either ET-1 concentration or its association with cardiovascular pathology at the time of initial surgery for CoA. While ET-1 activation is not thought to be causative of coarctation of the aorta, defining ET-1 activation in the perioperative period could offer significant insight as a marker of the variable short and long term physiologic responses to coarctation seen in this population.

Here we present a prospective, cohort study of ET-1 concentration and pathologic myocardial remodeling both prior to surgical correction of coarctation/aortic arch obstruction and in the immediate post-operative period. We sought to define pre-operative ET-1 activation, perioperative changes in concentrations with surgical relief, and the association with early myocardial change.

MATERIALS AND METHODS
=====================

The Colorado Multiple Institution Review Board approved this study. Written informed consent was obtained from the study subjects' parents in all cases. Written assent was obtained from all subjects aged between seven years and eighteen years.

Subjects
--------

We prospectively enrolled consecutive subjects (aged 0 to 18 years) undergoing surgical relief of coarctation of the aorta with or without associated transverse arch hypoplasia at Children's Hospital Colorado from September 2015 through January 2017. Exclusion criteria included patients with significant co-morbid heart disease, those with a prior intervention (surgical or trans-catheter) on their aortic arch, and those weighing less than 2 kg, due to limitations in acceptable sample blood volumes for research.

Clinical data
-------------

Clinical information was extracted from the electronic medical record (Epic Systems, Verona, WI). Demographic variables, peri-operative details, and key clinical variables were recorded. Study data were collected and managed using REDCap electronic data capture tools hosted at University of Colorado\[[@B12]\].

Laboratory data
---------------

Blood samples were obtained immediately prior to surgery and between 12-48 h post-operatively. Extracted plasma aliquots were then stored at -80 °C for batch analysis. ET-1 and B-type natriuretic peptide (BNP) analysis were performed by enzyme-linked immunosorbent assay (ELISA) per manufacturer's recommendations (R and D Systems, Inc. Minneapolis, MN).

Echocardiographic data
----------------------

Echocardiograms were obtained immediately prior to surgical repair and between 24 and 72 h post-operatively. All images were obtained with a GE Vivid E9 or E95 machine (General Electric, Chicago, Ill). Relative wall thickness (RWT) was measured at end-diastole from the parasternal short axis view as the ratio of the sum of the posterior and septal mural thickness to the left ventricular internal end-diastolic diameter; a value of 41% is conventionally taken as the upper limit of normal for RWT\[[@B4]\]. LV mass was calculated by the area-length (AL) method, indexed to height^2.7^, and compared to previously published normal values\[[@B13],[@B14]\].

Statistical analysis
--------------------

Demographics were summarized using descriptive statistics as indicated by the distribution of the data. Changes in echocardiographic indices were compared using the Signed-Rank test. Pearson's correlation test, two-sample *T*-Test, and general linear modeling compared ET-1 levels among groups and correlation with echocardiographic indices. All the statistical analyses were performed with SAS V9.4. The primary outcome for analysis was change in ET-1 concentration from the pre-operative to the post-operative sample. Other associations were tested as secondary outcomes. Statistician S Tong from University of Colorado, Denver reviewed the statistical methods of this study.

RESULTS
=======

Twenty-four patients were enrolled in the study. Their demographics and baseline/surgical characteristics are presented in Table [1](#T1){ref-type="table"}, represented as median (range) or *n* (%). Five patients, all \< 1 mo in age, underwent aortic arch reconstruction on cardio-pulmonary bypass, while the other nineteen underwent coarctectomy by lateral thoracotomy without bypass. Six patients (all in the neonatal cohort) had evidence of a patent ductus arteriosus on echocardiogram and were on prostaglandin infusion at the time of repair. In each of those six patients, ductal flow was right-to-left in systole, indicating that pressure in the pulmonary artery was equal to or greater than pressure in the aorta. One patient was on continuous milrinone. No patient received an endothelin receptor antagonist during the study period.

###### 

Demographics *n* (%)

  ------------------ -----------------
  Age (d)            356 (24039)
  Age class          
  ≤ 1 yr             12 (50)
  \> 1 yr            12 (50)
  Age class          
  ≤ 28 d             7 (29.2)
  28 d-1 yr          5 (20.8)
  \> 1 yr            12 (50)
  Weight preop       7.9 (3.1, 81.8)
  Weight postop      8.0 (2.9, 81.8)
  Race               
  African American   1 (4.2)
  White              20 (83.3)
  Hispanic           3 (12.5)
  Gender             
  Male               17 (70.8)
  Female             7 (29.2)
  ------------------ -----------------

Clinical presentation varied by age at diagnosis. Five of the neonates were diagnosed prenatally, started on prostaglandin within the first hours of life, and remained stable until repair. Two neonates presented within the first week of life with clinical evidence of decreased systemic perfusion and were medically stabilized before proceeding to operative repair. The patients between one month and one year of life had the greatest variability in clinical presentation, ranging from asymptomatic murmur to symptomatic left ventricular failure with decreased tissue oxygen delivery. Children older than one year were all clinically stable at presentation, referred for right upper extremity hypertension, decreased femoral pulses, or an asymptomatic murmur.

Pre-operative ET-1 concentration
--------------------------------

Pre-op ET-1 level in our entire cohort was 1.9 pg/mL (Figure [1](#F1){ref-type="fig"}). Patients \< 1-year-old showed significantly higher concentrations when compared to the older cohort. This effect was most pronounced among neonates, who demonstrated the highest levels.

![Serum endothelin-1 concentration. A: Pre-operative ET-1 concentration by age group; B: Comparison between pre-operative and post-operative levels for each age group. ^a,c^*P* \< 0.05. Scale bars represent standard deviation. ET-1: Endothelin-1.](WJC-9-822-g001){#F1}

Post-operative change in ET-1 concentration
-------------------------------------------

Analysis within age cohorts demonstrated two distinct patterns. Patients \< 1-year-old showed an immediate decline in ET-1 level post-op (Figure [1](#F1){ref-type="fig"}). Conversely, older children demonstrated no significant change between pre-op and post-op. Overall, patients with the highest levels of ET-1 pre-op demonstrated the greatest post-op decline while those with more modest ET-1 concentration pre-op tended to have unchanged levels after repair (Figure [2](#F2){ref-type="fig"}).

![Pre-Operative Endothelin-1 as a predictor. A: Correlation between pre-operative ET-1 concentration and post-operative RWT in the subset cohort of neonatal patients; B: Correlation between pre-operative ET-1 concentration and change in level from pre-operative to post-operative sample in the full cohort of patients. Points represent individual patients. ET-1: Endothelin-1; RWT: Relative wall thickness.](WJC-9-822-g002){#F2}

B-type natriuretic peptide concentration
----------------------------------------

For the entire population taken together, BNP concentration followed a right skewed distribution. Median pre-op BNP concentration was 73 pg/mL (upper limit of normal 99 pg/mL, range 21-4915). Neonatal subjects demonstrated significantly higher BNP levels than older children \[1752 (30-4915) pg/mL *vs* 35 (21-74) pg/mL, *P* \< 0.0001, represented as median (range)\]. Pre-operative BNP was moderately correlated with pre-operative ET-1 (r = 0.65; *P* = 0.0002). Post-operatively, neonatal patients demonstrated a significant decrease in BNP level \[1752 (30-4915) pg/mL *vs* 977 (192-2732) pg/mL, *P* = 0.02\] while the concentration was unchanged among older children \[35 (21-74) pg/mL *vs* 161 (124-451) pg/mL, NS\]. Post-operative BNP was moderately correlated with post-operative ET-1 (r = 0.73; *P* = 0.0001).

Echocardiography
----------------

Mean RWT (%) and left ventricle mass index (LVMI) (g/m^2.7^) were increased compared to normal values for all time points (Table [2](#T2){ref-type="table"}). As expected, there was no significant change in RWT or LVMI between the pre-op and post-operative echocardiograms. Overall, infants showed higher LVMI compared to older children but no significant difference in RWT.

###### 

Echocardiographic markers of left ventricle remodeling prior to and immediately following surgical coarctectomy

                            **Subjects**   **Preop**     **Posop**     ***P* value**
  ------------------------- -------------- ------------- ------------- ---------------
  Relative wall thickness                                              
  All subjects              24             0.41 (0.09)   0.42 (0.10)   NS
  Neonates (0-28 d)         7              0.44 (0.09)   0.47 (0.09)   NS
  Infants (29 d-1 yr)       5              0.43 (0.08)   0.40 (0.14)   NS
  Children (\> 1 yr)        12             0.39 (0.09)   0.39 (0.09)   NS
  LV mass index                                                        
  All subjects              24             49.4 (24.6)   51.6 (17.5)   NS
  Neonates (0-28 d)         7              50.2 (22.3)   57.6 (12.9)   NS
  Infants (29 d-1 yr)       5              79.7 (31.1)   72.0 (19.9)   NS
  Children (\> 1 yr)        12             36.4 (6.3)    39.6 (7.1)    NS

LV: Left ventricle.

ET-1 as a biomarker of remodeling
---------------------------------

Including the entire cohort, RWT and LVMI were compared between patients with lower and higher levels of ET-1. Patients with ET-1 \> 2 pg/mL pre-op demonstrated higher LVMI (65.7 g/m^2.7^ *vs* 38.5 g/m^2.7^, *P* = 0.004) and a trend towards higher RWT (45% *vs* 39%, *P* = 0.07) prior to repair. Additionally, pre-op ET-1 \> 2 pg/mL was associated with higher post-op LVMI and RWT. Among the neonatal cohort, pre-operative ET-1 showed a strong positive correlation with post-op RWT (Figure [2](#F2){ref-type="fig"}).

DISCUSSION
==========

This study is the first to assess early ET-1 activation and its association with LV remodeling at the time of surgery for coarctation of the aorta. Key findings include increased concentration among neonates preoperatively with a decline after anatomic correction. This pattern is contrasted with more modest ET-1 level before surgery in older children and no significant post-operative change. Taking all patients together, our population also shows higher levels of ET-1 concentration than previously reported normal controls\[[@B11]\]. Similar changes in ET-1 level surrounding anatomic correction of a congenital heart lesion have not previously been described. The variable pattern of ET-1 concentration seen among patients with similar anatomic lesions but different physiologies is also a novel finding.

Increasing evidence suggests that ET-1 activation is regulated in part by pulmonary vascular stress. While data conflict on whether pulmonary artery pressure or pulmonary blood flow is the primary effector, abnormalities in pulmonary vascular physiology are known to associate with alterations in serum ET-1 concentration\[[@B15]-[@B18]\]. Subgroup analysis of our data supports this relationship. The youngest subset of patients demonstrated the highest pre-operative ET-1 levels; these patients, in addition to manifesting high LV afterload, all demonstrated elevated pressure in the pulmonary arteries due either to ductal dependent systemic blood flow or as an upstream consequence of left atrial hypertension. Those same patients also had a post-operative decline in ET-1 level associated with the acute physiologic change (rapid normalization of pulmonary hemodynamics). The older children, with isolated high LV afterload physiology that is slower to resolve, experienced no change in ET-1 concentration from pre-op to post-op. The variable activation pattern between neonatal and older patients supports a role for the different pulmonary artery mechanics between the two subgroups affecting the variable ET-1 levels seen.

One potential confounder in the different pre-op to post-op ET-1 patterns described is the role of cardio-pulmonary bypass in post-op ET-1 concentration (a majority of neonates were repaired on bypass while all older children were repaired off pump). However, prior studies of pediatric patients undergoing bypass for the Fontan operation\[[@B19]\] and adult patients undergoing bypass for coronary artery bypass grafting\[[@B20]\] have demonstrated, on average, higher plasma ET-1 concentrations after bypass. And, the two neonates who underwent coarctectomy without bypass showed the same pattern of ET-1 concentration as the rest of the neonatal cohort. The observation that patients with different pre- and post-op physiologies undergoing bypass have widely variable peri-op ET-1 concentration patterns further supports the conclusion that the peri-op physiology likely plays the dominant role in ET-1 level, rather than bypass alone.

Our data also provide preliminary evidence for a separate pathway of ET-1 regulation associated with LV afterload. All patients in our cohort, including older coarctation subjects with isolated high LV afterload and otherwise normal physiology, have higher ET-1 concentration than previously reported normal controls\[[@B11]\]. Previous studies have suggested such a correlation in a similar population, showing increased ET-1 levels compared to controls in hypertensive adults with high afterload physiology\[[@B21]\]. One possible driver of ET-1 activation in this group is sympathetic nervous system activation. Norepinephrine, an endogenous catecholamine and effector of the sympathetic nervous system, is known both to be over-expressed in hypertensive patients\[[@B22]\] and to stimulate ET-1 production by the vascular endothelium\[[@B23]\]. Given the normal pulmonary hemodynamics in our older cohort and the mechanistic explanation offered by previous work, we posit that the ET-1 levels seen in this sub-group could reflect sympathetic activation due to the abnormality in LV and systemic vascular physiology. Future studies will be needed to confirm this hypothesis.

Individual patients who deviated from the typical clinical presentation for their age cohort provide further evidence for the two distinct mechanisms of ET-1 regulation. A neonate with a severe coarctation, acutely decreased LV function, and normal pulmonary artery pressure developed post-operative low cardiac output syndrome and his function was slow to recover. His ET-1 concentration increased slightly from the pre-operative to post-operative sample, consistent with the pattern typical of older children whose ET-1 level is likely driven by LV stress. An eight month old with severe coarctation, a dilated LV with poor systolic function, and near-systemic pulmonary artery pressure secondary to longstanding LV failure demonstrated rapidly improved pulmonary hypertension and LV function post-operatively. As would be expected, ET-1 activation in this patient more closely mirrored those in the neonatal cohort: Pre-operative ET-1 concentration was quite high and post-operative level was well below the pre-operative value.

Measured BNP concentration follows a similar trend to ET-1 concentration in this patient population. Neonatal patients have higher pre-operative BNP levels than their older counterparts and show a significant post-operative decline. Older children have lower BNP levels (normal in many cases) pre-operatively with no statistical change after surgical correction. These data suggest that neonates and some older infants experience a broad neuro-hormonal activation prior to coarctation repair in response to ventricular and potentially pulmonary artery stress and that surgical repair can result in early reversal of this neuro-hormonal activation in many patients. The specific role of BNP in this pathophysiology is not fully defined, and future studies will be needed to clarify the relationship with ET-1 and other markers of neuro-hormonal activation.

The echocardiographic data provide another layer of evidence for ET-1's potential role in the physiologic response to coarctation. Average LVMI and RWT in our patient population were significantly higher than previously published normal values and did not vary significantly through the perioperative period. This finding supports prior work demonstrating concentric LV remodeling and hypertrophy in the face of chronically high afterload with no immediate resolution following afterload reduction\[[@B6],[@B24],[@B25]\]. Mechanistically, animal studies have demonstrated that chronic ET-1 exposure induces cardiomyocyte hypertrophy *via* increased production of Extracellular Signal-Regulated Kinases 1 and 2 (ERK 1/2)\[[@B8],[@B9],[@B26]\]. Our data aligns with this finding, as patients with higher levels of ET-1 had more abnormal cardiac geometry. This novel finding combined with a biologically plausible link between ET-1 and myocyte hypertrophy raises the possibility that ET-1 could be not only a useful marker of LV remodeling but potentially an effector as well. Further, longitudinal studies will be needed to evaluate ET-1's role both in myocyte hypertrophy prior to repair and reverse remodeling after surgical correction.

In summary, we conclude that ET-1 concentration is significantly altered in patients with coarctation of the aorta undergoing surgical repair. We find preliminary evidence supporting two potentially distinct stimuli for ET-1: One mechanism, associated with high LV afterload and sympathetic nervous system activation, persists through the immediate post-operative period and the other, likely driven by altered pulmonary artery physiology, is rapidly reversible. We further find preliminary evidence supporting an association between ET-1 activity and early pathologic LV remodeling.

Limitations
-----------

This study is prospective, single center, and targets a relatively rare patient population. As such, statistical power was limited, particularly in sub-cohort analysis. Biological heterogeneity, particularly among patients between 1 mo and 1 year of age, also limited statistical analysis. Therefore, validation of these findings in similar cohorts at other centers will be of great importance. Our study design does not allow for conclusions regarding causality in the relationship between ET-1 level and LV remodeling. Due to the young age of the subject population, control serum samples for ET-1 analysis were not obtained. While historical controls from previous studies were noted for discussion, an ideal comparison including unaffected, age-matched controls will be a goal of future studies. Additionally, small patient size and safety concerns preclude routine direct clinical monitoring of pulmonary artery and left atrial pressure in the peri-operative period. While hemodynamic inferences can be drawn from available clinical data, future animal studies will be helpful to directly measure these pressures and more precisely elucidate their role in the physiology described.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

Patients with coarctation of the aorta are at risk for a variety of short- and long-term complications after surgical repair. Endothelin-1 (ET-1) is a peptide hormone known to cause both cardiac myocyte hypertrophy and vasoconstriction that has been linked to late ventricular hypertrophy in this population. Peri-operative endothelin concentration in this population has not been previously defined.

Research motivation
-------------------

Defining ET-1 activation in the perioperative period could offer significant insight into the variable short and long term physiologic responses to coarctation seen in this population.

Research objectives
-------------------

The authors sought to define pre-operative ET-1 activation, perioperative changes in concentrations with surgical relief, and the association with early myocardial change.

Research methods
----------------

Here authors present a prospective, cohort study of ET-1 concentration and pathologic myocardial remodeling both prior to surgical correction of coarctation/aortic arch obstruction and in the immediate post-operative period. ET-1 analysis was performed by ELISA. Echocardiograms were obtained immediately prior to surgical repair and between 24 and 72 h post-operatively. All images were obtained with a GE Vivid E9 or E95 machine (General Electric, Chicago, Ill). Relative wall thickness (RWT) was measured at end-diastole from the parasternal short axis view as the ratio of the sum of the posterior and septal mural thickness to the left ventricular internal end-diastolic diameter; a value of 41% is conventionally taken as the upper limit of normal for RWT. LV mass was calculated by the area-length (AL) method, indexed to height^2.7^, and compared to previously published normal values.

Research results
----------------

The authors demonstrate that neonates with coarctation of the aorta have high pre-operative ET-1 levels that decrease post-operatively. Older coarctation patients have more modest ET-1 activation that is unchanged post-operatively.

Research conclusions
--------------------

This study is the first to assess early ET-1 activation and its association with LV remodeling at the time of surgery for coarctation of the aorta. Key findings include increased concentration among neonates preoperatively with a decline after anatomic correction. This pattern is contrasted with more modest ET-1 level before surgery in older children and no significant post-operative change. The authors find preliminary evidence supporting two potentially distinct stimuli for ET-1: One mechanism, associated with high LV afterload and sympathetic nervous system activation, persists through the immediate post-operative period and the other, likely driven by altered pulmonary artery physiology, is rapidly reversible. The authors further find preliminary evidence supporting an association between ET-1 activity and early pathologic LV remodeling.

Research perspectives
---------------------

Longitudinal studies will be needed to evaluate ET-1's role both in myocyte hypertrophy prior to repair and reverse remodeling after surgical correction. Given the normal pulmonary hemodynamics in the author's older cohort and the mechanistic explanation offered by previous work, the authors posit that the ET-1 levels seen in this sub-group could reflect sympathetic activation due to the abnormality in LV and systemic vascular physiology. Future studies will be needed to confirm this hypothesis. The variable activation pattern between neonatal and older patients supports a role for the different pulmonary artery mechanics between the two subgroups affecting the variable ET-1 levels seen. Further studies will be needed to clarify the role of pulmonary artery pressure and pulmonary blood flow on ET-1 concentration.
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